Patient Decisions About Breast Cancer Chemoprevention: A Systematic Review and Meta-Analysis

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2013) David Moher   ANNALS OF INTERNAL MEDICINE

Women’s decisions regarding tamoxifen for breast cancer prevention: responses to a tailored decision aid

(2009) Angela Fagerlin et al.   BREAST CANCER RESEARCH AND TREATMENT

Recruitment to breast cancer clinical trials: What makes a difference?

(2009) M. D. Pinkowish   CA-A CANCER JOURNAL FOR CLINICIANS

Breast cancer chemoprevention - a vision not yet realized

(2009) P. BLAHA et al.   EUROPEAN JOURNAL OF CANCER CARE

American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction

(2009) Kala Visvanathan et al.   JOURNAL OF CLINICAL ONCOLOGY

Tamoxifen for Breast Cancer Risk Reduction

(2008) Joy Melnikow et al.   MEDICAL CARE